BRÈVE publiée le 10/01/2025 à 13:05, il y a 1 année 6 mois Lumira Ventures Promotes Suman Rao to Principal Healthcare Innovation Venture Capital Lumira Ventures Suman Rao Principal Promotion
BRÈVE publiée le 10/01/2025 à 13:05, il y a 1 année 6 mois Lumira Ventures promeut Suman Rao au poste de directeur Capital-risque Lumira Ventures Innovation Dans Le Domaine De La Santé Suman Rao Promotion Principale
COMMUNIQUÉ DE PRESSE publié le 10/01/2025 à 13:00, il y a 1 année 6 mois Lumira Ventures Announces Promotion of Suman Rao to Principal Lumira Ventures promotes Suman Rao, Ph.D., to Principal, recognizing her contributions to healthcare innovation. Read more about her journey and achievements Healthcare Innovation Venture Capital Lumira Ventures Biomedical Suman Rao
BRÈVE publiée le 26/06/2024 à 13:05, il y a 2 années Lumira Ventures Promotes Nikhil Thatte to Partner Promotion Life Sciences Lumira Ventures Healthcare Investment Nikhil Thatte
BRÈVE publiée le 26/06/2024 à 13:05, il y a 2 années Lumira Ventures promeut Nikhil Thatte comme partenaire Promotion Lumira Ventures Investissement Dans La Santé Sciences De La Vie Nikhil Thatte
COMMUNIQUÉ DE PRESSE publié le 26/06/2024 à 13:00, il y a 2 années Lumira Ventures Announces Promotion of Nikhil Thatte to Partner Lumira Ventures promotes Nikhil Thatte to Partner in recognition of his exceptional contributions to healthcare innovation. Nikhil's strategic insights drive firm's success and partnerships Life Sciences Healthcare Innovation Lumira Ventures Investment Firm Nikhil Thatte
BRÈVE publiée le 02/04/2024 à 13:05, il y a 2 années 3 mois Lumira Ventures Invests in Nocion Therapeutics to Advance Chronic Cough Treatment Lumira Ventures Nocion Therapeutics Chronic Cough Treatment Phase 2b Study Series B Financing
BRÈVE publiée le 02/04/2024 à 13:05, il y a 2 années 3 mois Lumira Ventures investit dans Nocion Therapeutics pour faire progresser le traitement de la toux chronique Lumira Ventures Financement De Série B Nocion Thérapeutique Traitement De La Toux Chronique Étude De Phase 2b
COMMUNIQUÉ DE PRESSE publié le 02/04/2024 à 13:00, il y a 2 années 3 mois Lumira Ventures Announces Investment in Nocion Therapeutics to Revolutionize Chronic Cough Treatment Lumira Ventures invests in Nocion Therapeutics' Taplucanium for Chronic Cough treatment. Series B funding of $70M secured from leading investors Series B Funding Lumira Ventures Nocion Therapeutics Taplucanium Chronic Cough
BRÈVE publiée le 07/03/2024 à 13:05, il y a 2 années 4 mois Lumira Ventures Celebrates Team Promotions Ahead of International Women's Day Healthcare Innovation Gender Equality International Women's Day Lumira Ventures Team Promotions
Publié le 22/07/2026 à 18:19, il y a 5 heures 17 minutes Covivio place avec succès 500 M€ d’obligations vertes à 7 ans
Publié le 22/07/2026 à 18:19, il y a 5 heures 17 minutes Covivio successfully places €500 million of 7-year European Green Bonds
Publié le 22/07/2026 à 17:45, il y a 5 heures 51 minutes Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Publié le 22/07/2026 à 17:45, il y a 5 heures 51 minutes Groupe CRIT : Chiffre d’affaires du 1er semestre 2026 : 1,67 Md€ (+2,3% en organique).
Publié le 22/07/2026 à 17:40, il y a 5 heures 56 minutes Report on share repurchases from 15 to 21 July 2026
Publié le 22/07/2026 à 15:00, il y a 8 heures 36 minutes Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Publié le 22/07/2026 à 15:00, il y a 8 heures 36 minutes Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Publié le 22/07/2026 à 14:35, il y a 9 heures 1 minute Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Publié le 22/07/2026 à 14:30, il y a 9 heures 6 minutes As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
Publié le 22/07/2026 à 22:20, il y a 1 heure 16 minutes Quantinuum Appoints Chief Legal Officer and Chief People Officer
Publié le 22/07/2026 à 21:01, il y a 2 heures 34 minutes EQS-Adhoc: Correction of a release from 22/07/2026, 20:08 CET/CEST - FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
Publié le 22/07/2026 à 20:44, il y a 2 heures 52 minutes EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on July 22, 2026
Publié le 22/07/2026 à 20:08, il y a 3 heures 28 minutes EQS-Adhoc: FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
